Sunway (SUNWAY) investor relations material

Executive summary

• Q2 FY2026 revenue rose 13.4% year-over-year to RM2.91 billion, driven by higher contributions from most segments except construction.

• Profit before tax increased 25.3% YoY to RM496.2 million, reflecting strong operating performance across most segments.

• Net profit attributable to shareholders (PATMI) was RM319 million, up from RM273 million in Q2 FY2025.

• For the six months ended June 2026, revenue increased 10.8% to RM5.46 billion and profit before tax surged to RM10.05 billion, mainly due to a one-off RM9.1 billion gain from the revaluation of Sunway Healthcare Holdings Berhad.

• A first interim dividend of 3.00 sen per ordinary share was declared for the six-month period ended 30 June 2026.

Financial highlights

• Revenue for Q2 FY2026: RM2.91 billion (Q2 FY2025: RM2.56 billion), up 13.4% YoY.

• Profit before tax: RM496.2 million (Q2 FY2025: RM396 million), up 25.3% YoY.

• PATMI: RM319 million (Q2 FY2025: RM273 million), up 17% YoY.

• Basic EPS for Q2 FY2026: 4.71 sen (Q2 FY2025: 4.07 sen), up 16% YoY.

• Net assets per share increased to RM3.65 as at 30 June 2026 from RM2.38 at end-2025.

Outlook and guidance

• Cautiously optimistic for FY2026, supported by diversified business model, robust unbilled sales, healthcare expansion, and record construction order book.

• Property development expects stable demand in Malaysia and robust growth in Singapore, supported by new land acquisitions and strong sales.

• Healthcare segment anticipates continued growth from capacity expansion and medical tourism, with licensed beds rising to 1,855 and further expansion underway.

• Construction segment revised its full-year order book replenishment target upwards to RM7.0–9.0 billion, underpinned by strong digital infrastructure demand.